Clinical and microbiological profiles of infective endocarditis in a tertiary hospital in Aseer region, Saudi Arabia  by Assiri, Abdullah S.
Journal of the Saudi Heart Association (2011) 23, 207–211King Saud University
Journal of the Saudi Heart Association
www.ksu.edu.sa
www.sha.org.sa
www.sciencedirect.comORIGINAL ARTICLEClinical and microbiological proﬁles of infective
endocarditis in a tertiary hospital in Aseer region,
Saudi ArabiaAbdullah S. Assiri *King Khalid University, College of Medicine, PO Box 641, Abha 61421, Saudi ArabiaReceived 17 November 2010; revised 28 March 2011; accepted 9 April 2011
Available online 21 April 2011*
E
10
El
Pe
doKEYWORDS
Endocarditis;
Echocardiography;
Microbiologic;
Culture negative;
Valvular heart disease;
Prosthetic valve;
Saudi ArabiaTel.: +966 504745956.
-mail address: aassiri@yaho
16-7315 ª 2011 King Saud
sevier B.V. All rights reserve
er review under responsibilit
i:10.1016/j.jsha.2011.04.002
Production and ho.com
Universit
d.
y of King
osting by EAbstract Objectives: We aimed to evaluate demographic data, underlying cardiac abnormalities,
clinical proﬁle, microbiological features, treatments and complications of infective endocarditis (IE)
in a tertiary hospital in Aseer region, Saudi Arabia.
Methods: A retrospective study of all cases with the diagnosis of deﬁnite endocarditis according to
modiﬁed Duke Criteria admitted to ACH between May 2002 and April 2007. Data were reviewed
on demographic and clinical data, underlying cardiac disease, microbiological ﬁndings, treatments
and complications of IE.
Results: The study included 44 patients (28 males and 16 females; mean age 31.1 ± 16 years; range
13–65 years). Infective endocarditis developed on a native valve in 31 (70.5%), a mechanical pros-
thetic valve in 10 (22.7%), mitral valve prolapse in 2 (4.5%) and ventricular septal defect in 1
(2.3%). Rheumatic heart disease in 31 cases (70.5%) was the most common preexisting valvular
abnormality in native valve endocarditis. The mitral valve was the most commonly affected valve
28 (63.6%). Fever occurred in 40 (90.9%) of the cases. Electrocardiography was abnormal in 34
cases (77.3%). Trans-thoracic and/or trans-esophageal echocardiography showed a vegetation in
22 (50%). Staphylococci in 10 cases (22.7%) and Streptococci in 8 cases (18%) were the most
common causative agents and cultures were negative in 20 cases (45.5%). Twenty-two patientsy. Production and hosting by
Saud University.
lsevier
208 A.S. Assiri(50%) underwent surgical treatment. Congestive heart failure occurred in 16 (36.4%) cases, atrial
ﬁbrillation in 6 (13.6%) cases, and cerebrovascular accidents in 4 (9%) cases.
Conclusion: Our data reﬂects the clinical and microbiological proﬁles of IE in a tertiary hospital in
Aseer region, Saudi Arabia.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Infective endocarditis (IE) is an infection of the endocardium
or the cardiac valves which is caused by different microbiolog-
ical organisms mainly bacterial but can be fungal, or less
commonly other rare organisms like Chlamydia and
Mycoplasma. Culture-negative endocarditis is considered to
be an important clinical entity (Houpikian and Raoult,
2005). Despite the recent advances in diagnosis and treatment
of patients with infective endocarditis, IE remains a serious life
threatening infection with a poor prognosis and a high mortal-
ity rate approaching 25% (Mylonakis and Calderwood, 2001).
This high mortality rate could be attributed to changing in the
microbiologic virulence of different organisms, increased use
of prosthesis and increased rate of invasive procedures (Hoen
et al., 2002; Moreillon and Que, 2004; Mouly et al., 2002;
Devlin et al., 2004).
Streptococcus species is the main causative microorganism.
However, recently, other pathogens have gained importance
(Ako et al., 2003). The modiﬁed Duke diagnostic criteria have
been used for case deﬁnition as deﬁnite or possible IE (Li et al.,
2000). The literature on proﬁle of infective endocarditis in Sau-
di Arabia is scarce.
The Aseer region (population of 1200,000) is located in the
southwest of Saudi Arabia covering an area of more than
80,000 km2. The region extends from the high mountains of
Sarawat (with an altitude of 3200 m above the sea level) to
the Red Sea. Health services delivery in Aseer region is pro-
vided by a network of 244 primary health care centers, 16
referral hospitals and one tertiary hospital, Aseer Central Hos-
pital (ACH). ACH, with 500 beds, is run by the Ministry of
Health and the College of Medicine of King Khalid University
(KKU) Abha.
In this study we aimed to evaluate the demographic, clinical
and microbiological proﬁles of IE in a tertiary hospital (Aseer
Central Hospital – ACH), Aseer Region, Saudi Arabia, during
the period between May 2002 and April 2007.
2. Methods
2.1. Study design
A systematic retrospective review of medical records of all pa-
tients admitted to ACH from May 2002 to April 2007 with the
diagnosis of deﬁnite endocarditis according to the modiﬁed
Duke criteria was included. Local institutional ethical ap-
proval was obtained.
2.2. Demographic and clinical data
Data from medical records were collected on the following
demographic variables: age, gender, nationality and site of res-
idency (high vs. low altitude area). Clinical presentation dataincluding symptoms, signs and ECG ﬁndings were noted.
Trans-thoracic or trans-esophageal echocardiography was per-
formed and data collected regarding; site and size of vegeta-
tion, valvular abnormality, type of underlying cardiac
abnormalities and any other abnormalities.
Pattern of antibiotics use and the rate of surgical interven-
tion as well as variable complications were reviewed and
recorded.
2.3. Microbiological data
Data were collected on all blood culture results, type of micro-
organism and antibiotics sensitivity. The laboratory used the
standard methods to identify the microorganism and the anti-
microbial sensitivity.
2.4. Statistical analysis
Descriptive statistics: (using means and standard deviations for
continuous variables and frequencies for qualitative variables),
using SPSS soft ware package.
3. Results
3.1. Demographic and clinical data
A total of 44 patients were admitted with the diagnosis of def-
inite endocarditis (28 men and 16 women); mean age
33.1 ± 16 years; and the range was 13–65 years. Table 1 shows
demographic data, clinical proﬁle, treatments and complica-
tions in patients with infective endocarditis – Aseer Central
Hospital–Saudi Arabia.
In our series the majority of patients were Saudis (77.3%)
and living in a high altitude area (77.3%). All symptoms and
signs were nonspeciﬁc and occurred in a signiﬁcant number
of patients. These symptoms included dyspnea in 24(54.5%),
cough in 16 (36.4%), sweating in 12 (27.3%), anorexia in 8
(18.2%), weight loss in 8 (18.2%), fatigue in 8 (18.2%),
myalgia in 4 (9%) and headache in 4 (9%) patients. But fever
was a constant clinical feature in 40 (90.9%) patients.
The ECG was abnormal in 34 (77.3%) patients. Different
ECG abnormalities observed included: left ventricular strain
in 14 (31.8%), left atrial enlargement in 8 (18.2%), Sinus
tachycardia in 8 (18.2%), atrial ﬁbrillation in 6 (13.6%), right
axis deviation in 6 (13.6%) and others (supra-ventricular
tachycardia, right ventricular strain, ventricular bigeminy,
bundle branch block and T-wave changes) in 4.5% of patients.
All patients received at least two intravenous antibiotics
according to the culture results, and in cases of culture-nega-
tive endocarditis, empirical antibiotics therapy was applied.
Surgical treatment was required in 22 (50%) patients, out of
them 12 (54.5%) patients required mitral valve replacement
and 10 (45.5%) patients required aortic valve replacement.
Table 2 Distribution of the underlying cardiac lesion and type
of valve involved in patients with infective endocarditis – Aseer
Central Hospital–Saudi Arabia.
N %
Underlying cardiac lesion
Rheumatic 31 70.5
Prosthesis 10 22.7
MVP 2 4.5
VSD 1 2.3
Valve involved
Native 33 75
Prosthetic 10 22.7
Native valves:
Mitral 20 45.5
Aortic 12 27.3
Tricuspid 1 2.3
Prosthetic valves
Mitral 8 18.2
Aortic 2 4.5
Table 3 Distribution of the causative microorganisms in
patients with infective endocarditis – Aseer Central Hospital–
Saudi Arabia.
N %
Microorganism
Staphylococcus aureus 8 18.2
Streptococcus viridians 6 13.6
Enterococcus faecalis 4 9.1
Staphylococcus epidermidis 2 4.5
Streptococcus pneumoni 2 4.5
Mycoplasma 2 4.5
Culture negative 20 45.5
Table 1 Demographic data, clinical proﬁle, treatment and
complications in patients with infective endocarditis – Aseer
Central Hospital–Saudi Arabia.
N % Mean + SD
Age (years) 34.5 + 16
Gender
Male 28 63.6
Female 16 36.4
Nationality
Saudi 34 77.3
Non-Saudi 10 22.7
Site of residency
High altitude 34 77.3
Low altitude 10 22.7
Presence of fever
Yes 40 90.9
No 04 9.1
Abnormal ECG
Yes 34 77.3
No 10 22.7
Surgery performed
Yes 22 50
No 22 50
Complications
Heart failure 16 36.4
Atrial Fibrillation 6 13.6
Stroke 4 9
SVT (Supraventricular tachycardia) 2 4.5
Pneumonia 2 4.5
Renal failure 2 4.5
Peripheral septic emboli 2 4.5
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ure in 36%, atrial ﬁbrillation in 13.6% and stroke in 9% of
patients.Trans-thoracic and/or trans-esophageal echocardiography
was/were performed on all patients and showed vegetations
in 24 (54.5%) of patients. The average size of vegetations
was +6.9 mm. Vegetations were seen on the mitral valve in
16 (36.4%) patients and on the aortic valve in 8 (18.2%)
patients.
Other echocardiographic ﬁndings included moderate to
severe mitral regurgitation in 18 (40.9%) patients, moderate
to severe aortic regurgitation in 14 (31.8%) patients, mitral ste-
nosis in 12 (27.3%) patients, severe tricuspid regurgitation in 8
(18.2%) patients, aortic stenosis in 2 (4.5%) patients, mitral
valve prolapse in tow patients (4.5%) and ventricular septal
defect in one patient (2.27%).
Table 2 shows distribution of the underlying cardiac lesion
and type of valve involved. Rheumatic heart disease (70.5%)
was the commonest underlying cardiac problem, while pros-
thesis was the underlying problem in (22.7%) of patients.
Mitral valve was the most commonly affected valve in our
series, in both native valves (45%) and prosthetic valves endo-
carditis (18.2).
3.2. Microbiologic data
Table 3 shows distribution of the causative microorganisms
isolated from blood cultures. Staphylococci (22.7%) and
streptococci (18.2%) were the most commonly isolated
causative agents of IE, accounting for a total of 40.9% of all
the isolated microorganisms. Cultures remain negative in 20
cases (45.5%).
4. Discussion
In our series a total of 44 patients who fulﬁlled the modiﬁed
Duke criteria for deﬁnite IE were reviewed. The mean age of
our patients was 33.1 ± 16 years which is similar to the mean
age reported in Tunisia which was 32.4 ± 16.8 years (Letaief
et al., 2007), but younger than the mean age reported in Eur-
ope which was more than 50 years (Hoen et al., 2002; Hill
et al., 2007; Cecchi et al., 2004). The discrepancy of age is likely
due to the decreased incidence of rheumatic heart disease in
Europe while it is still a common problem in developing
countries.
The majority of cases in our study were living in a high alti-
tude area (77.3%). An old animal study suggested that high
altitude is a risk factor for development of IE in dogs but hu-
man studies are lacking (Altland and Highman, 1957).
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Male sex predilection as a risk factor for the development of
I.E has been observed in previous studies, and it was found this
gender preference decreases with aging (Durante-Mangoni
et al., 2008). The well recognized protective effect of female
hormones on endothelial cell function and platelet aggregation
thus protecting from atherosclerosis may affect the likely hood
of developing IE (Tsang et al., 2000).
Among the presenting symptoms, fever was observed in the
vast majority of our patients (90.9%), which is similar to
observations from earlier literature (Ferreiros et al., 2006;
Chu et al., 2004; Schulz et al., 1996). However, absence of fever
cannot rule out the diagnosis of IE as patients without fever
may still have IE (Loupa et al., 2004).
The role of echocardiography in diagnosing IE is well
established with a very high rate of speciﬁcity approaching
98% (Cabell et al., 2002). In our series echocardiography
was the mainstay of diagnosis of IE.
Staphylococci species especially Staphylococci aureus was
the most prevalent causative microorganism in our study
(22.7%), followed by Streptococci species in (18.2%) of cases.
This shift of pattern from the usual prevalence of streptococci
species has been reported in recent studies (Mouly et al., 2002;
Fowler et al., 2005; Baddour et al., 2005). It seems that in the
last decade staphylococci have exceeded the streptococci spe-
cies in causing IE with concomitant decrease in the incidence
of Streptococci viridance (Ferreiros et al., 2006; Chu et al.,
2004; Loupa et al., 2004; Cabell et al., 2002; Fowler et al.,
2005; Lerakis and Martin, 2005). Previous studies showed that
culture negative endocarditis accounts for 30–45% of all cases
of IE (Letaief et al., 2007; Krcmery et al., 2007). In our series it
accounted for 45.5% of cases. This high rate in our series could
be attributed to prior antibiotics therapy and lack of optimal
culture techniques that isolate rare microorganisms. A study
on culture negative IE showed that most of the cases (48%)
were associated with Coxilla Burnetii, and 78% were associ-
ated with intracellular bacteria (Houpikian and Raoult, 2005).
The outcome of endocarditis is affected negatively by the
presence of complications mainly heart failure and stroke
(Iung et al., 2007; Eishi et al., 1995). These tow complications
occurred in a signiﬁcant proportion of our patients (36.4% and
9%), respectively. Among complications in our series we found
relatively a high rate of atrial ﬁbrillation (A.F) 13.6%, which
can be explained by the high rate of rheumatic heart disease
which can predispose to A.F.
In our series 50% of patients required surgery mainly valve
replacement. Similar rate was observed in other studies (Hoen
et al., 2002; Mouly et al., 2002; Tornos et al., 2005). This rel-
atively high rate of surgical intervention may reﬂect the severe
nature of the disease we observed in this cohort of patients.
Rheumatic heart disease still remains the most prevalent
underlying cardiac risk factor for developing IE and it oc-
curred in 70.5% of cases in our series. Globally, an estimated
12 million people are affected by acute rheumatic fever and
rheumatic heart disease. In contrast, rheumatic heart disease
has markedly decreased in prevalence in last few decades in
developed countries. The estimated annual incidence of acute
rheumatic fever in underdeveloped countries (up to 150 cases
per 100,000 population vs. that of developed countries <1 case
per 100,000 population) has been reported (World Health Or-
gan. Tech. Rep. Ser., 2004).The commonest valve affected in our series was the mitral
valve; this predilection of mitral valve was reported in the
other study (Hoen et al., 2002). This is likely due to the predi-
lection of mitral valve by rheumatic heart disease.
The main limitations of this study are its retrospective nat-
ure and the relatively small sample size.
In conclusion, literature on IE in Saudi Arabia is scarce,
and we believe this study shed some light on the protean nature
of IE in Asseer region, Saudi Arabia. It described the clinical
and the microbiologic features of this disease. Our patients
are of younger age group and had more severe form of the dis-
ease. Rheumatic heart disease is still the main cardiac risk fac-
tor. Efforts in preventing acute rheumatic fever will likely
contribute to decrease in the incidence of rheumatic heart dis-
ease and thus the incidence of IE.
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